journal article·2017-04-03Open access

Biotin decorated PLGA nanoparticles containing SN-38 designed for cancer therapy

Mozhdeh Mehdizadeh, Hasti Rouhani, Nima Sepehri, Reyhaneh Varshochian, Mohammad Hossein Ghahremani, Mohsen Amini, Mehdi Gharghabi, Seyed Nasser Ostad, Fatemeh Atyabi, Azin Baharian, Rassoul Dinarvand

Abstract

Active targeted chemotherapy is expected to provide more specific delivery of cytotoxic drugs to the tumor cells and hence reducing the side effects on healthy tissues. Due to the over expression of biotin receptors on cancerous cells as a result of further requirement for rapid proliferations, biotin can be a good candidate as a targeting agent. In this study, biotin decorated PLGA nanoparticles (NPs) containing SN-38 were prepared and in vitro studies were evaluated for their improved anti-cancer properties. In conclusion, biotin targeted PLGA NPs containing SN-38 showed preferential anticancer properties against tumor cells with biotin receptor over expression.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Graphene and Nanomaterials Applications · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran;

Nano Alvand Co., Avicenna Tech Park, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran;

Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran;

Department of Toxicology-Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran;

Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran

References (37)

Show source-provided references
1. 10.1016/j.jconrel.2013.07.02210.1016/j.jconrel.2013.07.022 ↗
2. 10.1158/1078-0432.CCR-07-144110.1158/1078-0432.CCR-07-1441 ↗
3. 10.1016/j.jconrel.2010.08.02710.1016/j.jconrel.2010.08.027 ↗
4. 10.2147/IJN.S1890510.2147/IJN.S18905 ↗
5. Ebrahimnejad P · J Pharm Sci Technol · 2009 · 63 · 512
6. 10.1073/pnas.060175510310.1073/pnas.0601755103 ↗
7. 10.1016/S0168-3659(98)00116-310.1016/S0168-3659(98)00116-3 ↗
8. 10.1039/C005154C10.1039/C005154C ↗
9. 10.1016/j.jconrel.2013.10.01210.1016/j.jconrel.2013.10.012 ↗
10. Kawato Y · Can Res · 1991 · 51 · 4187
11. 10.1016/j.ijpharm.2012.01.03410.1016/j.ijpharm.2012.01.034 ↗
12. 10.1016/j.jconrel.2014.06.04610.1016/j.jconrel.2014.06.046 ↗
13. 10.1016/j.jconrel.2011.09.06310.1016/j.jconrel.2011.09.063 ↗
14. 10.1016/j.jconrel.2014.05.02510.1016/j.jconrel.2014.05.025 ↗
15. 10.1007/s00280-002-0463-110.1007/s00280-002-0463-1 ↗
16. 10.1016/j.jconrel.2009.01.02110.1016/j.jconrel.2009.01.021 ↗
17. 10.1016/j.biomaterials.2008.09.05610.1016/j.biomaterials.2008.09.056 ↗
18. Prasad S · Int J Pharm Pharm Sci · 2014 · 6 · 685
19. 10.1007/s11095-014-1313-710.1007/s11095-014-1313-7 ↗
20. 10.1016/j.jinorgbio.2004.07.00910.1016/j.jinorgbio.2004.07.009 ↗
21. 10.3324/haematol.2009.00827610.3324/haematol.2009.008276 ↗
22. 10.1016/j.ijpharm.2014.05.04110.1016/j.ijpharm.2014.05.041 ↗
23. 10.1155/2014/96350710.1155/2014/963507 ↗
24. 10.1016/j.ijpharm.2014.05.04610.1016/j.ijpharm.2014.05.046 ↗
25. 10.1016/j.biomaterials.2007.09.03810.1016/j.biomaterials.2007.09.038 ↗
26. 10.1166/jbn.2011.134010.1166/jbn.2011.1340 ↗
27. Taheri A · Int J Nanomed · 2011 · 6 · 1863
28. 10.1007/s11095-008-9800-310.1007/s11095-008-9800-3 ↗
29. 10.1016/S0168-3659(03)00241-410.1016/S0168-3659(03)00241-4 ↗
30. 10.1016/j.jconrel.2014.06.03810.1016/j.jconrel.2014.06.038 ↗
31. 10.1002/wnan.133910.1002/wnan.1339 ↗
32. Yellepeddi VK · Anticancer Res · 2011 · 31 · 897
33. 10.1016/j.biomaterials.2013.04.05210.1016/j.biomaterials.2013.04.052 ↗
34. 10.1016/j.jconrel.2012.12.01910.1016/j.jconrel.2012.12.019 ↗
35. 10.1016/j.jconrel.2014.03.02610.1016/j.jconrel.2014.03.026 ↗
36. 10.1038/sj.clpt.610040010.1038/sj.clpt.6100400 ↗
37. 10.1016/j.actbio.2015.11.03110.1016/j.actbio.2015.11.031 ↗